Company: LGN
Filing Date: 2025-08-25
Form Type: S-1/A
Source: 0001193125-25-186788
Chunk: 177

Company: Legence Corp.
Filing Date: 2025-08-25
Form: S-1/A
Chunk 177
---
 projects to receive certain vaccines. Project-specific requirements may
cause delays in initiating or completing such projects as we seek to hire qualified personnel or acquire appropriate materials. Further, our relative unfamiliarity with certain regimes may increase our risk of noncompliance.

Failure to comply with applicable regulations, however, could cause delays, subject us to lawsuits, substantial fines, revocation of our
operating licenses, and/or give rise to termination or cancellation rights under our contracts or disqualify us from future bidding opportunities, among other things. Further, we incur substantial costs in complying with, and monitoring our
compliance with applicable rules and regulations. See the sections titled “Risk Factors—Risks Related to Regulations” and “Risk Factors—Risks Related to the Environment, Health and Safety” for additional
information.

Legal Proceedings

We
are party to various legal proceedings and claims in the ordinary course of our business. We believe these matters will not have a material adverse effect on our business, financial condition or results of operations. See Note 17 of our Consolidated
Financial Statements for additional information about these legal proceedings.

128

MANAGEMENT Directors and Executive Officers The following table sets forth the names, ages and titles of our directors, director nominee and executive officers:

| Name                    |     | Age |     | Title                                |
| Jeffrey Sprau           |     |  60 |     | Chief Executive Officer and Director |
| Stephen Butz            |     |  54 |     | Chief Financial Officer              |
| Gregory Barnes          |     |  46 |     | Chief Human Resources Officer        |
| Bryce Seki              |     |  49 |     | General Counsel and Secretary        |
| Bilal Khan              |     |  44 |     | Director                             |
| Robert Mitchell Nimocks |     |  36 |     | Director                             |
| Terrence Keenen         |     |  65 |     | Director Nominee                     |

Jeffrey Sprauis our Chief Executive Officer and a director. Mr. Sprau has served as our Chief Executive Officer since January 2025, as director on our board of directors since August 2025, and as the Chief Executive Officer of Legence Parent since October 2020, when he was also appointed to Legence Parent’s Board of Managers. Prior to the formation of Legence Parent, since April 2019, Mr. Sprau served as the Chief Executive Officer of Therma Holdings LLC, the predecessor to Legence Parent. Prior to joining